UPCUPCHealthcare · Drug Manufacturers - Specialty & Generic

UPC Stock Forecast: Universe Pharmaceuticals, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$1.08

Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 25 of 100 as at 21 Nov 2026 — in the lower half.

Market cap
$5.9M
Ticker Nerd rank
25/ 100
Median analyst target
—
Analysts covering
—
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Universe Pharmaceuticals, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
25/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth
63
Quality
52
Momentum
49
Accruals
30
Issuance
26
Revisions
20
Value
17
Volatility
8

Growth (63): Sales and profits are climbing, and climbing faster than before.

Volatility (8): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

UPC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on UPC, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

UPC appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Estimates

UPC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
0.3×

Cheaper than 86% of US stocks

Price / book
0.0×

Cheaper than 99% of US stocks

EV / EBITDA
—
Growth & margins
Revenue growth (YoY)
−1.3%

Higher than 26% of US stocks

Earnings growth (YoY)
—
Gross margin
—
Operating margin
−11.8%

Higher than 25% of US stocks

Net margin
−10.9%

Higher than 20% of US stocks

Returns & dividend
Return on equity
−3.5%

Higher than 41% of US stocks

Return on assets
−1.7%

Higher than 38% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Universe Pharmaceuticals, Inc. has a market value of $5.9M.

  • Shares outstanding: 647,838.

  • Universe Pharmaceuticals, Inc. employs 216 people.

market figures as at 20 Nov 2026

Data provided by Twelve Data

Peers

UPC and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelDrug Manufacturers - Specialty & Generic
CompanyMarket capTKN rank
UPCUniverse Pharmaceuticals, Inc.$5.9M25
YCBDcbdMD, Inc.$4.0M31
SNOASonoma Pharmaceuticals, Inc.$3.7M21
BFRIBiofrontera, Inc.$9.5M66
APUSApimeds Pharmaceuticals US, Inc.$3.0M11
GELSGelteq Ltd.$2.9M10
AKANAkanda Corp.$11.1M14

Take a look at UPC’s peer groups, ranked by the model: healthcare stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Universe Pharmaceuticals, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about UPC

How does Ticker Nerd's model rank UPC?

As at 21 Nov 2026, Universe Pharmaceuticals, Inc. ranks 25 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Growth (63 of 100).

What is the UPC stock forecast for 2030?

No analyst covering Universe Pharmaceuticals, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for UPC are extrapolating price history, which says nothing about the business.

What does Universe Pharmaceuticals, Inc. do?

Universe Pharmaceuticals Inc. Class A Ordinary Shares represents the equity of a China-based pharmaceutical company focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. The company also offers biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements sourced from third-party manufacturers.

Company

About Universe Pharmaceuticals, Inc.

Universe Pharmaceuticals Inc. Class A Ordinary Shares represents the equity of a China-based pharmaceutical company focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. The company also offers biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements sourced from third-party manufacturers. Its product portfolio is designed to address common health conditions, including chronic ailments associated with aging, as well as cold and flu needs. Operating through its subsidiaries, Universe Pharmaceuticals serves customers in domestic and international markets and participates in the broader healthcare supply chain through production, distribution, and commercialization activities. Headquartered in Ji’an, Jiangxi, China, the company issues Class A ordinary shares as part of a dual-class share structure that is used in its corporate governance framework.

CEO Mr. Gang Lai · 216 employees · China · https://www.universe-pharmacy.com